Eduardo Vilar

Sensei: how many samples to tell a change in cell type abundance?

Vakul Mohanty, Jason Willis, Shaoheng Liang, 2022, BMC Bioinform..

Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract

Ken Chen, John Paul Shen, Eduardo Vilar, 2020, Genes.

Clinical utility of circulating cell-free DNA in advanced colorectal cancer

Eduardo Vilar, I. Shureiqi, S. Kopetz, 2017, PloS one.

Cancer: Pinprick diagnostics

Eduardo Vilar, Josep Tabernero, J. Tabernero, 2012, Nature.

Abstract 5371: Drug repositioning with a bioinformatics platform that integrates the TCGA, cMap and CCLE

Jerry Fowler, Eduardo Vilar, Scott Kopetz, 2014 .

Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing

Tara Srinivasan, Tuo Zhang, Todd Evans, 2017, Nature Medicine.

Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine

Sean V Tavtigian, Elena M Stoffel, Laura Valle, 2019, The Journal of pathology.

Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?

Eduardo Vilar, E. Vilar, R. Barnett, 2018, Journal of the National Cancer Institute.

Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer

Yong Wang, Alexander Davis, Ruli Gao, 2017, Genome research.

Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway

Bhramar Mukherjee, Stephen B Gruber, Rork Kuick, 2009, Clinical Cancer Research.

High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.

Y Nancy You, Eduardo Vilar, E. Vilar, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.